EvolveImmune United, Inc
1 clinical trials · Sponsor
◉ Watch EvolveImmune United, Inc
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas (NCT07217171) | EvolveImmune United, Inc | 2025-11-13 |
Track EvolveImmune United, Inc automatically
Every clearance here is in the API, with alerts when new ones post.